Dr Monica Nordstrom and Rakhi Patel lead on the Respiratory Research within the Trust.
They have undertaken various advanced respiratory clinical trials over the years, which often offer patients treatment which will enhance their quality of life. Dealing with respiratory conditions can have a major impact on a patient’s well-being and so being able to offer these interventional clinical trials is of great importance. During an investigator meeting in Rome in January 2017, St Peter’s respiratory research team was noted to be top respiratory research recruiter for pharmaceutical company Astra Zeneca. This accolade is due to their continued dedication to clinical trials and a passion for enhancing the treatment on offer for respiratory patients.
The team are currently looking for patients to take part in a moderate to severe Asthma Study, which has been described by The Guardian and BBC News, as a potential "game-changer" in the treatment of uncontrolled asthma. This study will aim to add to previous research which found that patients taking Fevipiprant once daily had fewer inflammatory cells in their phlegm and airways, a significant decrease of asthma symptoms and an improvement to their lung function with reduced inflammation of the lungs.
More research is needed, but it's an exciting development.
If you wish to take part in this exciting New Asthma study Please call the Respiratory team at St Peter’s Hospital on 01932 722310